Alcon Inc (ALC)
78.84
-0.73
(-0.92%)
USD |
NYSE |
Apr 25, 16:00
78.67
-0.17
(-0.22%)
Pre-Market: 08:20
Alcon Revenue (TTM): 9.455B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.455B |
| September 30, 2023 | 9.274B |
| June 30, 2023 | 9.085B |
| March 31, 2023 | 8.88B |
| December 31, 2022 | 8.717B |
| September 30, 2022 | 8.695B |
| June 30, 2022 | 8.657B |
| March 31, 2022 | 8.55B |
| December 31, 2021 | 8.291B |
| September 30, 2021 | 8.082B |
| Date | Value |
|---|---|
| June 30, 2021 | 7.818B |
| March 31, 2021 | 6.922B |
| December 31, 2020 | 6.833B |
| September 30, 2020 | 6.806B |
| June 30, 2020 | 6.836B |
| March 31, 2020 | 7.525B |
| December 31, 2019 | 7.508B |
| September 30, 2019 | 7.386B |
| June 30, 2019 | 7.28B |
| March 31, 2019 | 7.197B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.806B
Minimum
Sep 2020
9.455B
Maximum
Dec 2023
8.032B
Average
8.082B
Median
Sep 2021
Revenue (TTM) Benchmarks
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | 1.787M |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 7.797M |